We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
-9.77%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
AUM
$162M
AUM Growth
-$40.1M
Cap. Flow
-$22.4M
Cap. Flow %
-13.79%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
TNGX icon
Tango Therapeutics
TNGX
+$22.4M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNGX icon
1
Tango Therapeutics
TNGX
$4.43B
$130M 80.09%
16,859,075
-2,342,400
-12% -$22.4M
PLRX icon
2
Pliant Therapeutics
PLRX
$64.4M
$23.9M 14.75%
2,132,867
FULC icon
3
Fulcrum Therapeutics
FULC
$273M
$8.37M 5.16%
2,343,154

Similar funds

TRV GP IV's Q3 2024 Portfolio in Review

As of Q3 2024, TRV GP IV held 3 positions worth $162M, down 20% from $202M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP IV withdrew a net $22.4M in Q3 2024, reducing 1 holding. Its largest reduction was Tango Therapeutics, cutting an estimated $22.4M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV's biggest Q3 2024 reduction was Tango Therapeutics, cutting an estimated $22.4M.
  • TRV GP IV's ten largest holdings make up 100% of its $162M portfolio in Q3 2024.
  • TRV GP IV opened 0 new positions and closed 0 in Q3 2024.
  • TRV GP IV's portfolio value fell 20% quarter-over-quarter to $162M.

Based on TRV GP IV's 13F filing for Q3 2024, filed 6 Nov 2024.